---
title: "Arcutis Biotherapeutics jumps amid takeover speculation"
date: "2025-02-12 23:26:30"
summary: "Arcutis Biotherapeutics (NASDAQ:ARQT) rose 12% amid some takeover speculation. The biotech is speculated to have attracted some takeover interest, according to traders, who cited a Betaville \"uncooked\" alert that circulated on Wednesday. An unidentified European company is said to be interested. Arcutis (NASDAQ:ARQT) is set to report Q4 results on..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1252840886/image_1252840886.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Arcutis Biotherapeutics (NASDAQ:[ARQT](https://seekingalpha.com/symbol/ARQT "Arcutis Biotherapeutics, Inc.")) rose 12% amid some takeover speculation.

The biotech is speculated to have attracted some takeover interest, according to traders, who cited a Betaville "uncooked" alert that circulated on Wednesday. An unidentified European company is said to be interested.

Arcutis (NASDAQ:[ARQT](https://seekingalpha.com/symbol/ARQT "Arcutis Biotherapeutics, Inc.")) is set to [report Q4 results on Feb. 25.](https://seekingalpha.com/pr/19966774-arcutis-announces-preliminary-unaudited-fourth-quarter-product-revenue-and-full-year-2024 "report Q4 results on Feb. 25.")

Arcutis ([ARQT](https://seekingalpha.com/symbol/ARQT "Arcutis Biotherapeutics, Inc.")) has [short interest of 17%.](https://seekingalpha.com/symbol/ARQT "short interest of 17%.")

[seekalpha](https://seekingalpha.com/news/4407170-arcutis-biotherapeutics-jumps-amid-takeover-speculation)
